Profile data is unavailable for this security.
About the company
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
- Revenue in INR (TTM)22.14bn
- Net income in INR2.95bn
- Incorporated1962
- Employees3.33k
- LocationUnichem Laboratories LtdUnichem BhavanOff S.V.Road, Prabhat EstateJogeshwari (West)MUMBAI 400102IndiaIND
- Phone+91 2 266888333
- Fax+91 2 226784391
- Websitehttps://www.unichemlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indoco Remedies Ltd | 17.58bn | -1.14bn | 19.40bn | 6.05k | -- | -- | 303.72 | 1.10 | -12.52 | -12.52 | 197.86 | -- | -- | -- | -- | 2,905,519.00 | -- | 4.84 | -- | 6.87 | 71.18 | 65.70 | -6.62 | 5.16 | -- | -0.3334 | -- | 17.11 | -8.38 | 8.51 | -174.89 | -- | 43.53 | -7.79 |
| Solara Active Pharma Sciences Ltd | 12.55bn | -191.10m | 21.77bn | 1.78k | -- | -- | 27.61 | 1.73 | -4.81 | -4.81 | 330.32 | -- | -- | -- | -- | 7,068,733.00 | -- | -3.27 | -- | -5.35 | 51.77 | 39.95 | -1.52 | -6.17 | -- | 0.7946 | -- | -- | -0.4003 | -0.5816 | 100.10 | -65.75 | -31.71 | -- |
| Morepen Laboratories Ltd | 17.87bn | 994.48m | 21.87bn | 1.81k | 21.99 | -- | 14.84 | 1.22 | 1.81 | 1.81 | 32.65 | -- | -- | -- | -- | 9,850,214.00 | -- | 8.14 | -- | 12.81 | 33.71 | 31.83 | 5.61 | 5.91 | -- | 5.59 | -- | -- | 7.17 | 16.26 | 22.73 | 28.58 | 65.86 | -- |
| Bliss GVS Pharma Ltd | 8.60bn | 1.10bn | 22.01bn | 966.00 | 20.18 | 1.94 | 14.93 | 2.56 | 10.31 | 10.31 | 80.97 | 107.18 | 0.6414 | 3.38 | 1.87 | 8,905,504.00 | 8.60 | 6.04 | 10.41 | 7.54 | 50.76 | 46.33 | 13.42 | 9.45 | 3.86 | 8.37 | 0.043 | 8.27 | 5.13 | 3.27 | 11.72 | -2.82 | 5.18 | 0.00 |
| Panacea Biotec Ltd | 6.04bn | -72.40m | 22.94bn | 1.29k | -- | 2.78 | 87.41 | 3.80 | -1.18 | -1.18 | 98.44 | 134.92 | 0.4836 | 1.38 | 8.67 | 4,681,039.00 | -0.6085 | 13.08 | -0.8291 | 19.61 | 58.47 | 48.06 | -1.26 | 30.99 | 0.9785 | -14.33 | 0.0271 | 0.00 | -0.0132 | 0.5466 | -613.56 | -- | 48.74 | -- |
| Hikal Ltd | 16.99bn | 101.00m | 23.33bn | 2.06k | 230.33 | 1.95 | 14.44 | 1.37 | 0.8216 | 0.8216 | 137.81 | 96.86 | 0.7065 | 2.01 | 4.59 | 8,239,573.00 | 0.42 | 4.78 | 0.6016 | 7.00 | 55.49 | 48.00 | 0.5945 | 5.71 | 0.5418 | 1.11 | 0.3639 | 14.83 | 4.21 | 4.29 | 30.46 | 1.46 | -2.77 | 3.13 |
| IOL Chemicals and Pharmaceuticals Ltd | 21.70bn | 1.16bn | 23.76bn | 2.89k | 20.50 | 1.36 | 12.32 | 1.09 | 3.95 | 3.95 | 73.97 | 59.66 | 0.9278 | 3.77 | 4.39 | 7,507,091.00 | 4.95 | 10.26 | 6.48 | 13.42 | 34.01 | 32.57 | 5.34 | 9.33 | 1.32 | 9.37 | 0.0832 | 13.68 | -2.51 | 1.88 | -24.82 | -22.49 | 21.61 | 5.92 |
| Unichem Laboratories Ltd | 22.14bn | 2.95bn | 27.20bn | 3.33k | 9.24 | -- | 6.49 | 1.23 | 41.79 | 41.79 | 314.32 | -- | -- | -- | -- | 6,654,374.00 | -- | -0.5598 | -- | -0.6977 | 54.06 | 55.09 | 13.32 | -1.18 | -- | 3.47 | -- | -- | 18.25 | 13.85 | 246.67 | -- | -18.68 | -- |
| SMS Pharmaceuticals Ltd | 8.97bn | 895.91m | 29.83bn | 1.47k | 31.45 | -- | 23.76 | 3.32 | 10.13 | 10.13 | 101.51 | -- | -- | -- | -- | 6,102,851.00 | -- | 5.58 | -- | 7.66 | 32.55 | 33.78 | 9.71 | 8.05 | -- | 5.85 | -- | 5.72 | 10.36 | 13.70 | 38.75 | 16.97 | 23.62 | 9.86 |
| Gufic BioSciences Ltd | 8.74bn | 569.19m | 31.80bn | 1.99k | 55.84 | 5.04 | 37.47 | 3.64 | 5.68 | 5.68 | 87.10 | 62.94 | 0.7354 | 1.87 | 2.75 | 4,394,322.00 | 4.79 | 10.27 | 7.34 | 16.11 | 55.47 | 46.41 | 6.52 | 10.48 | 1.06 | 3.13 | 0.3691 | 1.31 | 1.63 | 16.69 | -19.14 | 25.15 | 13.64 | 14.87 |
| Dishman Carbogen Amcis Ltd | 27.97bn | 1.19bn | 32.91bn | 1.11k | 27.71 | -- | 7.35 | 1.18 | 7.57 | 7.57 | 178.50 | -- | -- | -- | -- | 25,287,880.00 | -- | -0.7247 | -- | -0.9005 | 84.96 | 74.27 | 4.25 | -2.77 | -- | 1.31 | -- | -- | 3.66 | 5.82 | 102.11 | -54.07 | -11.91 | -- |
| RPG Life Sciences Ltd | 6.74bn | 2.03bn | 34.26bn | 1.33k | 16.91 | -- | 15.31 | 5.09 | 122.51 | 122.51 | 407.37 | -- | -- | -- | -- | 5,061,758.00 | -- | 21.05 | -- | 27.78 | 64.34 | 63.28 | 30.07 | 16.68 | -- | 174.47 | -- | 24.92 | 12.26 | 11.71 | 109.03 | 44.58 | 27.39 | 37.97 |
| Aarti Drugs Ltd | 25.22bn | 2.03bn | 34.64bn | 1.28k | 17.19 | -- | 13.01 | 1.37 | 22.07 | 22.07 | 274.99 | -- | -- | -- | -- | 19,639,960.00 | -- | 9.09 | -- | 14.39 | 36.35 | 22.09 | 8.03 | 8.08 | -- | 7.00 | -- | 6.07 | -5.60 | 5.74 | -1.90 | 3.53 | 29.85 | 14.87 |
| Orchid Pharma Ltd | 8.21bn | 522.57m | 34.92bn | 737.00 | 66.80 | 2.74 | 40.14 | 4.25 | 10.31 | 10.31 | 162.05 | 251.16 | 0.4893 | 1.58 | 3.94 | 11,143,480.00 | 3.10 | 1.40 | 3.63 | 1.72 | 39.83 | 35.89 | 6.33 | 2.75 | 1.90 | 2.18 | 0.181 | -- | 12.48 | 13.76 | 8.13 | -- | 104.06 | -- |
Data as of Feb 11 2026. Currency figures normalised to Unichem Laboratories Ltd's reporting currency: Indian Rupee INR
10.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 5.46m | 7.75% |
| DSP Asset Managers Pvt. Ltd.as of 31 Dec 2025 | 852.06k | 1.21% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 635.15k | 0.90% |
| quant Money Managers Ltd.as of 30 Jan 2026 | 147.73k | 0.21% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 34.45k | 0.05% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 28.29k | 0.04% |
| DFA Australia Ltd.as of 31 Dec 2025 | 5.97k | 0.01% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 1.19k | 0.00% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025 | 652.00 | 0.00% |
| Bandhan AMC Ltd.as of 31 Dec 2025 | 259.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
